Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01086397 · ClinicalTrials.gov registry record
Epidemiologic Study Of The Distribution Of Vaccine-Type Streptococcus Pneumoniae Serotypes In Adults In The US With Community-Acquired Pneumonia
A clinical trial of Vaccines, Pneumococcal and Pneumonia, Pneumococcal, sponsored by Pfizer.
- Completed
- Registry status
- 782
- Enrollment target
- 14
- Study locations
NCT01086397: Completed study of Vaccines, Pneumococcal and Pneumonia, Pneumococcal, sponsored by Pfizer.
NCT01086397 is a study of Vaccines, Pneumococcal and Pneumonia, Pneumococcal that has completed, run by Pfizer. The registered enrollment target is 782 participants. The trial reports 14 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01086397, a study of Vaccines, Pneumococcal and Pneumonia, Pneumococcal, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- 782 participants
- Enrollment target
- 14
- Study locations
Study Summary
The main purpose of this study is to use an investigational urine assay to estimate the proportion of pneumonia in adults 50 years or older in different areas throughout the US that is caused by certain types of the bacteria Streptococcus pneumoniae (also called pneumococcus).
Conditions Studied
Interventions
- PROCEDURE Urine sample collection
Study Locations (14)
Massachusetts
- Baystate Infectious Diseases Clinical Research - Springfield
- University of Massachusetts Memorial Medical Center - Worcester
- University of Massachusetts Memorial Medical Center - Worcester
Michigan
- Detroit Receiving Hospital - Detroit
- Sinai Grace Hospital - Detroit
Alabama
- University of South Alabama Division of Clinical Research - Mobile
California
- Sharpe-Grossmont Hospital - La Mesa
Florida
- Tampa General Hospital - Tampa
Illinois
- Northwestern Memorial Hospital - Chicago
Nevada
- eStudySite - Las Vegas
Ohio
- Summa Infectious Diseases - Akron
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 782 participants |
| Start Date | 2010-02 |
| Est. Completion | 2011-10 |
What the finished NCT01086397 record still lists
NCT01086397 is an observational study that tracks outcomes without assigning an intervention. The registered 782 participants enrollment target is mid-sized for trials with a published cap.
The record links to 2 conditions, with Vaccines, Pneumococcal appearing as the primary indexed condition, and to 1 intervention - of which Urine sample collection is the first listed.
NCT01086397 lists 14 locations in 11 states (Massachusetts, Michigan, Alabama).
Frequently Asked Questions
What is clinical trial NCT01086397 about?
NCT01086397 is a clinical study titled "Epidemiologic Study Of The Distribution Of Vaccine-Type Streptococcus Pneumoniae Serotypes In Adults In The US With Community-Acquired Pneumonia". The main purpose of this study is to use an investigational urine assay to estimate the proportion of pneumonia in adults 50 years or older in different areas throughout the US that is caused by certain types of the bacteria Streptococcus pneumoniae (also called pneumococcus).
What is the current status of trial NCT01086397?
This trial is currently completed. The enrollment target is 782 participants. The study started on 2010-02. Estimated completion is 2011-10.
What conditions does trial NCT01086397 study?
This clinical trial studies the following conditions: Vaccines, Pneumococcal, Pneumonia, Pneumococcal.
What interventions are being tested in trial NCT01086397?
The interventions under investigation include: Urine sample collection (PROCEDURE).
Who is sponsoring clinical trial NCT01086397?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01086397 being conducted?
This trial has 14 study locations across Alabama, California, Florida, Illinois, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vaccines, Pneumococcal
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06575192 · 783 participants · Phase 3
Evaluation of the Safety and Effectiveness of ARTIA Reconstructive Tissue Matrix Breast Reconstruction (ADORA) in Adult Participants
- NCT06118723 · 784 participants
The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
- NCT05046613 · 780 participants
Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant
- NCT05100862 · 780 participants · Phase 3
A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia